Embecta Corp. (EMBC) at a glance
Embecta Corp. (EMBC) is a micro-cap Healthcare company. It trades at $4.93, with a P/E of 1.6, a 10.7% profit margin and revenue decline of 14.4%. It pays a 14.9% dividend yield. Vestovix scores it 67/100 overall. Its strongest dimension is Income (97/100) and its weakest is Growth (21/100). Its volatility is roughly in line with the market.
- Price
- $4.94
- Market cap
- $183.9M
- P/E ratio
- 1.6
- Dividend yield
- 14.86%
- Beta
- 0.81
- 52-week range
- $2.77 to $15.55
Value
96
Growth
21
Income
97
Safety
80
Momentum
25
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield